{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:06:42Z","timestamp":1793387202183,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.coviro.2024.101423","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T14:51:56Z","timestamp":1719327116000},"page":"101423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals"],"prefix":"10.1016","volume":"67","author":[{"given":"Felix","family":"Fiehn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Beisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5805-6109","authenticated-orcid":false,"given":"Marco","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2024.101423_sbref1","series-title":"Hepatitis C Virus: The Story of a Scientific and Therapeutic Revolution","year":"2020"},{"key":"10.1016\/j.coviro.2024.101423_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41575-022-00608-8","article-title":"Breakthroughs in hepatitis C research: from discovery to cure","volume":"19","author":"Manns","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_sbref3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(23)01320-X","article-title":"Hepatitis C","volume":"402","author":"Martinello","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.coviro.2024.101423_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.coviro.2024.101423_bib5","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021) results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2022."},{"key":"10.1016\/j.coviro.2024.101423_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2023.09.010","article-title":"Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis","volume":"80","author":"Colapietro","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_sbref6","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/hep.32434","article-title":"Risk factors for HCC in contemporary cohorts of patients with cirrhosis","volume":"77","author":"Kanwal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2024.101423_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/v10100538","article-title":"Oncogenic signaling induced by HCV infection","volume":"10","author":"Virz\u00ec","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2024.101423_bib9","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/onc.2010.594","article-title":"Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer","volume":"30","author":"McGivern","year":"2011","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.coviro.2024.101423_sbref9","doi-asserted-by":"crossref","first-page":"e20210408","DOI":"10.1084\/jem.20210408","article-title":"Persistent RNA virus infection is short-lived at the single-cell level but leaves transcriptomic footprints","volume":"218","author":"Reuther","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2024.101423_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003934","article-title":"Inferring viral dynamics in chronically HCV infected patients from the spatial distribution of infected hepatocytes","volume":"10","author":"Graw","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.coviro.2024.101423_bib12","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1073\/pnas.1516879113","article-title":"Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue","volume":"113","author":"Harouaka","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.coviro.2024.101423_bib13","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jhep.2017.07.025","article-title":"Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression","volume":"67","author":"Waziry","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_sbref13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12091653","article-title":"Oxidative stress in liver pathophysiology and disease","volume":"12","author":"Allameh","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.coviro.2024.101423_sbref15","first-page":"1","article-title":"Reactive oxygen species bridge the gap between chronic inflammation and tumor development","volume":"2022","author":"Yu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.coviro.2024.101423_bib17","first-page":"1409582","article-title":"Flaviviridae viruses and oxidative stress: implications for viral pathogenesis","volume":"2019","author":"Zhang","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.coviro.2024.101423_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01351-6","article-title":"A state-of-the-art review on the NRF2 in Hepatitis virus-associated liver cancer","volume":"21","author":"Kalantari","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.coviro.2024.101423_sbref18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcmgh.2023.03.004","article-title":"High-resolution genomic profiling of liver cancer links etiology with mutation and epigenetic signatures","volume":"16","author":"Perez","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_bib20","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"Ally","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2024.101423_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-34249-x","article-title":"Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets","volume":"13","author":"Fujita","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2024.101423_sbref21","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s12094-022-02859-y","article-title":"HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt\/\u03b2-catenin signaling pathway during the progression of HCC","volume":"24","author":"Wang","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.coviro.2024.101423_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01081-9","article-title":"Targeting ER stress\/PKA\/GSK-3\u03b2\/\u03b2-catenin pathway as a potential novel strategy for hepatitis C virus-infected patients","volume":"21","author":"Lin","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.coviro.2024.101423_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040790","article-title":"Additional inhibition of Wnt\/\u03b2-catenin signaling by metformin in DAA treatments as a novel therapeutic strategy for HCV-infected patients","volume":"10","author":"Lin","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.coviro.2024.101423_bib25","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/cam4.4571","article-title":"Hepatocellular carcinoma after a sustained virological response by direct-acting antivirals harbors TP53 inactivation","volume":"11","author":"Imamura","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.coviro.2024.101423_bib26","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037093","article-title":"Hepatitis C virus replication","volume":"10","author":"Tabata","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.coviro.2024.101423_sbref26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.31656","article-title":"Inhibition of long noncoding RNA Linc-Pint by hepatitis C virus in infected hepatocytes enhances lipogenesis","volume":"74","author":"Khatun","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2024.101423_bib28","article-title":"Lipid alterations in chronic liver disease and liver cancer","volume":"4","author":"Paul","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.coviro.2024.101423_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-09588-w","article-title":"Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis","volume":"12","author":"Sheridan","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2024.101423_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123152","article-title":"HCV infection and liver cirrhosis are associated with a less-favorable serum cholesteryl ester profile which improves through the successful treatment of HCV","volume":"10","author":"Weigand","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.coviro.2024.101423_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/j.gastro.2019.04.003","article-title":"Combined analysis of metabolomes, proteomes, and transcriptomes of hepatitis c virus\u2013infected cells and liver to identify pathways associated with disease development","volume":"157","author":"Lupberger","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2024.101423_sbref31","doi-asserted-by":"crossref","first-page":"1033314","DOI":"10.3389\/fimmu.2022.1033314","article-title":"What role for cellular metabolism in the control of hepatitis viruses?","volume":"13","author":"Diaz","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2024.101423_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/apt.16706","article-title":"Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver","volume":"55","author":"Kim","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coviro.2024.101423_bib34","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/jvh.13167","article-title":"Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virological response","volume":"26","author":"Peleg","year":"2019","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.coviro.2024.101423_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269641","article-title":"Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: role of metabolic derangement and host genetic variants","volume":"17","author":"Chuaypen","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2024.101423_bib36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/hepr.13899","article-title":"Hepatitis C virus eradication by direct-acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low-density lipoprotein cholesterolemia without an increase in body weight","volume":"53","author":"Tokuchi","year":"2023","journal-title":"Hepatol Res"},{"key":"10.1016\/j.coviro.2024.101423_sbref36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009889","article-title":"Hepatitis C virus induces oxidation and degradation of apolipoprotein B to enhance lipid accumulation and promote viral production","volume":"17","author":"Wang","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2024.101423_bib38","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/hep4.1271","article-title":"Mitochondrial oxidative stress and antioxidants balance in fatty liver disease","volume":"2","author":"Garc\u00eda-Ruiz","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.coviro.2024.101423_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111410","article-title":"Hepatitis C virus downregulates core subunits of oxidative phosphorylation, reminiscent of the Warburg effect in cancer","volume":"8","author":"Gerresheim","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.coviro.2024.101423_bib40","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/cen.13924","article-title":"Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure","volume":"90","author":"Lim","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.coviro.2024.101423_bib41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/1348-0421.13023","article-title":"Hepatitis C virus, insulin resistance, and diabetes: a review","volume":"66","author":"Alzahrani","year":"2022","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.coviro.2024.101423_sbref41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jhep.2022.01.029","article-title":"Metabolic dysfunction and cancer in HCV: shared pathways and mutual interactions","volume":"77","author":"Leslie","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.coviro.2024.101423_sbref42","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/jcm10050991","article-title":"CD8(+) T cell responses during HCV infection and HCC","volume":"10","author":"Hofmann","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.coviro.2024.101423_sbref43","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jhep.2020.09.022","article-title":"T cell immunity to hepatitis C virus: lessons for a prophylactic vaccine","volume":"74","author":"Thimme","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_sbref44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/gutjnl-2021-325918","article-title":"Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification","volume":"72","author":"Montironi","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.coviro.2024.101423_sbref45","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32283-3","article-title":"A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma","volume":"13","author":"Lu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2024.101423_bib47","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2147\/JHC.S325959","article-title":"Molecular signature and immune landscape of HCV-associated hepatocellular carcinoma (HCC): differences and similarities with HBV-HCC","volume":"8","author":"De Battista","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.coviro.2024.101423_bib48","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"Cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coviro.2024.101423_sbref48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3350\/cmh.2022.0032","article-title":"Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment","volume":"29","author":"Park","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"22","key":"10.1016\/j.coviro.2024.101423_bib50","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026184118","article-title":"Hepatitis C virus modulates signal peptide peptidase to alter host protein processing","volume":"118","author":"Hirano","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.coviro.2024.101423_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.coviro.2024.101423_bib52","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jhep.2016.12.019","article-title":"Increased peripheral CD4 + regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C","volume":"66","author":"Langhans","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10020221","article-title":"Immunological mechanisms for hepatocellular carcinoma risk after direct-acting antiviral treatment of hepatitis C virus infection","volume":"10","author":"Sung","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.coviro.2024.101423_bib54","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2024.101423_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-023-03150-y","article-title":"Tumour cells can escape antiproliferative pressure by interferon-\u03b2 through immunoediting of interferon receptor expression","volume":"23","author":"Hiebinger","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.coviro.2024.101423_bib56","doi-asserted-by":"crossref","first-page":"1133308","DOI":"10.3389\/fimmu.2023.1133308","article-title":"Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2024.101423_bib57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trsl.2019.02.006","article-title":"The double edge sword of fibrosis in cancer","volume":"209","author":"Chandler","year":"2019","journal-title":"Transl Res"},{"key":"10.1016\/j.coviro.2024.101423_bib58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hep.32341","article-title":"HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: a meta-analysis","volume":"76","author":"Lockart","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2024.101423_bib59","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.cgh.2022.04.013","article-title":"Fibrosis stage-specific incidence of hepatocellular cancer after hepatitis C cure with direct-acting antivirals: a systematic review and meta-analysis","volume":"21","author":"Kim","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_bib60","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jhep.2021.07.003","article-title":"Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response","volume":"75","author":"Montaldo","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_bib61","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/ndt\/gfaa301","article-title":"Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches","volume":"37","author":"Landolt","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.coviro.2024.101423_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2015.00059","article-title":"Signaling in fibrosis: TGF-\u03b2, WNT, and YAP\/TAZ converge","volume":"2","author":"Piersma","year":"2015","journal-title":"Front Med"},{"key":"10.1016\/j.coviro.2024.101423_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.coviro.2024.101423_bib64","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.3390\/cancers13092270","article-title":"Molecular crosstalk between the hepatitis C virus and the extracellular matrix in liver fibrogenesis and early carcinogenesis","volume":"13","author":"Reungoat","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.coviro.2024.101423_sbref64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417152","article-title":"New and old key players in liver cancer","volume":"24","author":"Cuesta","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coviro.2024.101423_bib66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41576-021-00416-x","article-title":"Interplay between chromatin marks in development and disease","volume":"23","author":"Janssen","year":"2022","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.coviro.2024.101423_bib67","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41576-020-0270-8","article-title":"The evolving metabolic landscape of chromatin biology and epigenetics","volume":"21","author":"Dai","year":"2020","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.coviro.2024.101423_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105801","article-title":"Histone modifications and non-coding RNAs: mutual epigenetic regulation and role in pathogenesis","volume":"23","author":"Bure","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coviro.2024.101423_bib69","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.coviro.2024.101423_sbref69","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10030551","article-title":"Tracking down the epigenetic footprint of HCV-induced hepatocarcinogenesis","volume":"10","author":"Domovitz","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.coviro.2024.101423_bib71","article-title":"Epigenetic mechanisms involved in HCV-induced hepatocellular carcinoma (HCC)","volume":"11","author":"Zhao","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.coviro.2024.101423_bib72","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3389\/fmicb.2017.01833","article-title":"Long non-coding RNAs in hepatitis C virus-infected cells","volume":"8","author":"Barriocanal","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2024.101423_sbref72","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1002\/hep.32042","article-title":"The pannexin 1\/purinergic receptor P2X4 pathway controls the secretion of microRNA-containing exosomes by HCV-infected hepatocytes","volume":"74","author":"Kim","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2024.101423_bib74","article-title":"Vesiculated long non-coding RNAs: offshore packages deciphering trans-regulation between cells, cancer progression and resistance to therapies","volume":"3","author":"Fatima","year":"2017","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.coviro.2024.101423_bib75","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/onc.2016.340","article-title":"A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets","volume":"36","author":"Wijetunga","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.coviro.2024.101423_sbref75","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2019.02.038","article-title":"HCV-induced epigenetic changes associated with liver cancer risk persist after sustained virologic response","volume":"156","author":"Hamdane","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2024.101423_sbref76","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/gutjnl-2019-318918","article-title":"Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma","volume":"70","author":"J\u00fchling","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.coviro.2024.101423_sbref77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008181","article-title":"Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals","volume":"15","author":"Perez","year":"2019","journal-title":"PLoS Genet"},{"key":"10.1016\/j.coviro.2024.101423_bib79","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.32111","article-title":"Interferon drives HCV scarring of the epigenome and creates targetable vulnerabilities following viral clearance","volume":"75","author":"Hlady","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2024.101423_sbref79","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/jgh3.12833","article-title":"Persistent epigenetic alterations in transcription factors after a sustained virological response in hepatocellular carcinoma","volume":"6","author":"Sugimachi","year":"2022","journal-title":"JGH Open"},{"key":"10.1016\/j.coviro.2024.101423_sbref80","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jhep.2020.08.006","article-title":"Hepatic benefits of HCV cure","volume":"73","author":"Calvaruso","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_sbref81","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series\u2606","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_sbref82","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jhep.2022.08.042","article-title":"Reverse inflammaging: long-term effects of HCV cure on biological age","volume":"78","author":"Oltmanns","year":"2023","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.coviro.2024.101423_bib84","doi-asserted-by":"crossref","first-page":"e01784-20","DOI":"10.1128\/JVI.01784-20","article-title":"Induction of HOX genes by hepatitis C virus infection via impairment of histone H2A monoubiquitination","volume":"95","author":"Kasai","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2024.101423_bib85","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jhep.2021.11.023","article-title":"Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules","volume":"76","author":"Sanduzzi-Zamparelli","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_sbref85","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2024.101423_sbref86","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jcmgh.2023.04.006","article-title":"Identification of a transmembrane protein involved in shear stress signaling and hepatocarcinogenesis after a sustained virological response to hepatitis C virus","volume":"16","author":"Nishikawa","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_bib88","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/carcin\/bgab014","article-title":"Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus","volume":"42","author":"Takeda","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.coviro.2024.101423_bib89","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04801-4","article-title":"Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patients","volume":"21","author":"Caponigro","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.coviro.2024.101423_bib90","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.medj.2021.03.017","article-title":"A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis","volume":"2","author":"Fujiwara","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.coviro.2024.101423_bib91","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhep.2022.08.036","article-title":"Blood-based biomarkers for hepatocellular carcinoma screening: approaching the end of the ultrasound era?","volume":"78","author":"Parikh","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_bib92","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.32779","article-title":"Risk stratification and early detection biomarkers for precision HCC screening","volume":"78","author":"Lee","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2024.101423_sbref92","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jhep.2023.05.042","article-title":"Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antivirals","volume":"79","author":"Minami","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_bib94","doi-asserted-by":"crossref","first-page":"138","DOI":"10.14309\/ajg.0000000000001503","article-title":"A 2-step strategy combining FIB-4 with transient elastography and ultrasound predicted liver cancer after HCV cure","volume":"117","author":"Ampuero","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coviro.2024.101423_bib95","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.cgh.2020.07.065","article-title":"Validation of the updated hepatocellular carcinoma early detection screening algorithm in a community-based cohort of patients with cirrhosis of multiple etiologies","volume":"19","author":"Tayob","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_sbref95","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.32181","article-title":"BMS-986263 in patients with advanced hepatic fibrosis: 36\u2013week results from a randomized, placebo-controlled phase 2 trial","volume":"75","author":"Lawitz","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2024.101423_sbref96","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jhep.2022.09.019","article-title":"Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan","volume":"78","author":"Tsai","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2024.101423_bib98","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1002\/hep4.1991","article-title":"Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature","volume":"6","author":"Kim","year":"2022","journal-title":"Hepatol Commun"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625724000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625724000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T01:24:25Z","timestamp":1730078665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625724000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":98,"alternative-id":["S1879625724000373"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2024.101423","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2024.101423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101423"}}